Showing 3531-3540 of 7262 results for "".
- Daily Aspirin Linked to Higher Melanoma Risk in Menhttps://practicaldermatology.com/news/daily-aspirin-linked-to-higher-melanoma-risk-in-men/2457779/Men who take once-daily aspirin have nearly double the risk of melanoma compared to men who don’t, reports a new Northwestern Medicine study. Women, however, do not have an increased risk in this large patient population, the study showed. The study collected medical record
- Tutublue Launches Men's Line of Sunsafe Activewearhttps://practicaldermatology.com/news/tutu-blue-launches-mens-line-of-sunsafe-activewear/2457780/Tutublue, the sun-protective activewear brand, is unveiling a line of men's rash guards and full suits for Summer 2018. Tutublue, designed by California actress and entrepreneur
- DermTech Partners with Melanoma Research Foundation to Support Miles for Melanomahttps://practicaldermatology.com/news/dermtech-partners-with-melanoma-research-foundation-to-support-miles-for-melanoma/2457781/DermTech, Inc. is partnering with the Melanoma Research Foundation in support of five Miles for Melanoma Runs/Walks held throughout the US, kicking off this month during Melanoma Awareness
- Bath Emollients Don't Add Much to Standard Eczema Carehttps://practicaldermatology.com/news/bath-emollients-dont-add-much-to-standard-eczema-care/2457784/Emollient bath additives provide no meaningful benefit when used in addition to standard eczema care in children, according to research in the BMJ. UK researchers, led by Miriam Santer, MBBChir
- FDA Approves Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600-Mutant Melanomahttps://practicaldermatology.com/news/fda-approves-tafinlar-mekinist-for-adjuvant-treatment-of-braf-v600-mutant-melanoma/2457786/The FDA has approved Novartis' Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations, as detected by an FDA-approved test, and involvement of lymph node(s), following complete resection. The FDA
- Cellulite Market Expected to Growhttps://practicaldermatology.com/news/cellulite-market-expected-to-grow/2457792/The cellulite treatment market is expected to grow worldwide, as the obesity epidemic grows. Findings are in the comprehensive research report by Future Market Insights entitled “Cellulite Treatment Market
- Melanoma Reduces Alzheimer's Risk: Studyhttps://practicaldermatology.com/news/melanoma-reduces-alzheimers-risk-study/2457794/Individuals diagnosed with malignant melanoma may have a reduced risk of developing Alzheimer's disease. New findings, recently published online in
- Marriage May Reduce Risk of Dying from Melanomahttps://practicaldermatology.com/news/marriage-may-reduce-risk-dying-from-melanoma/2457797/Married folks are more likely to spot a melanoma early, compared with individuals who were never married, divorced or widowed, a new study shows. Researchers tracked data from more tha
- Study: Derms More Likely than PAs to Catch Early Skin Cancerhttps://practicaldermatology.com/news/study-derms-more-likely-than-pas-to-catch-early-skin-cancer/2457800/Physician assistants may be more likely than dermatologists to perform unnecessary skin biopsies to check for cancer and are less likely to accurately diagnose early stage skin cancers, according to new research conducted by the University of Pittsbur
- Dermatologist Publishes Practice Planning Guide, "Moxie Mindset"https://practicaldermatology.com/news/dermatologist-publishes-practice-planning-guide-moxie-mindset/2457804/New York City dermatologist Dina D. Strachan, MD has published "Moxie Mindset," a book that offers "secrets of building a profitable, independent physicians practice in a competitive environment." Dr. Strachan details her personal journey to building a thriv